Tag Archives: Andy Kim

Nearly Every House Republican Votes Against Codifying Right to Contraception

“If they had the chance they would ban it,” said Rep. Ilhan Omar (D-Minn.).

By Julia Conley Published 7-21-2022 by Common Dreams

Screenshot: C-SPAN

With many lawmakers expressing disbelief that a law codifying the right to use birth control is needed in the U.S. in 2022, House Democrats passed the Right to Contraception Act on Thursday—joined by just eight Republicans as the party denied access to contraception is under attack.

All 220 Democrats voted in favor of the bill.

“One hundred ninety-five House Republicans just voted against protecting your right to access contraception,” said Rep. Bonnie Watson Coleman (D-N.J.). Continue reading →

Big Pharma Spent ‘Horrifying’ Sums of Money to Weaken Drug Price Reform

The industry is expected to break its lobbying record after spending tens of millions of dollars to undermine a popular proposal to reduce prescription drug costs.

By Kenny Stancil. Published 11-5-2021 by Common Dreams

Photo: Daniel Foster/flickr/CC

While progressive advocates are still optimistic that a limited drug pricing provision will be included in the Build Back Better Act, the Washington Post on Friday detailed the “massive, months-long advertising, lobbying, and political donation blitz” that Big Pharma and its allies carried out to kill a stronger and overwhelmingly popular proposal that would have done more to protect Americans from the industry’s deadly price gouging.

As Common Dreams has reported, pharmaceutical corporations and private health insurers spent $171 million on lobbying through the first nine months of the year, the most of any industry. Big Pharma’s 1,600 lobbyists outnumber members of Congress by a ratio of three to one. Continue reading →

Occupy World Writes

The Movement Continues – Globally

Tag Archives: Andy Kim

Big Pharma Spent ‘Horrifying’ Sums of Money to Weaken Drug Price Reform

The industry is expected to break its lobbying record after spending tens of millions of dollars to undermine a popular proposal to reduce prescription drug costs.